Advertisement

Effect of tofacitinib on the expression of noggin/BMP-4 and hair growth stimulation in mice

  • J. Meephansan
  • T. Pongcharoensuk
  • J. Thummakriengkrai
  • S. Ponnikorn
  • W. Yingmema
  • R. Deenonpoe
Concise Communication
  • 51 Downloads

Abstract

Many hair loss disorders, including non-scaring alopecia, are caused by the arrest of hair follicles at the telogen phase, and the failure to enter the growth phase. Several studies report the efficacy of tofacitinib in promoting hair growth, by mechanisms not precisely known. The aim of this study was to identify other mechanisms by which tofacitinib, applied topically, promotes hair growth. The results showed that histopathological studies in mice treated topically with tofacitinib increased number of hair follicles, ratio of hair follicles in anagen phase, and length of hair infundibulum, and a reduced interfollicular epidermal thickness, compared to DMSO-treated mice. RT-PCR experiments showed significant increases in the expression of noggin (P < 0.05) and BMP4 (P < 0.05) mRNAs, which were greater than those in the vehicle-controlled group. Moreover, the expression of noggin and BMP4 mRNAs was significantly higher in the tofacitinib-treated group than in the minoxidil-treated group. This study would help understand the efficacy and mechanism by which tofacitinib, applied topically, triggers noggin and BMP4 mRNA expression, both being important molecules involved in the onset of the growth phase of hair growth cycles.

Keywords

Tofacitinib Hair growth BMP4 Noggin 

Notes

Acknowledgements

The authors express sincere gratitude to the financial support provided by Chulabhorn International College of Medicine, Thammasat University, Thailand.

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to declare.

References

  1. 1.
    Amberg N, Holcmann M, Stulnig G, Sibilia M (2016) Effects of imiquimod on hair follicle stem cells and hair cycle progression. J Invest Dermatol 136:2140–2149CrossRefGoogle Scholar
  2. 2.
    Botchkarev VA (2003) Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. J Invest Dermatol 120(1):36–47CrossRefGoogle Scholar
  3. 3.
    Botchkarev VA, Botchkareva NV, Nakamura M, Huber O, Funa K, Lauster R, Paus R, Gilchrest BA (2001) Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J 15(12):2205–2214CrossRefGoogle Scholar
  4. 4.
    Cohen S, Fleischmann R (2010) Kinase inhibitors: a new approach to rheumatoid arthritis treatment. Curr Opin Rheumatol 22(3):330–335CrossRefGoogle Scholar
  5. 5.
    Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Izpisua Belmonte JC, Choe S (2002) Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420(6916):636–642CrossRefGoogle Scholar
  6. 6.
    Harel S, Higgins CA, Cerise JE, Dai Z, Chen JC, Clynes R, Christiano AM (2015) Pharmacologic inhibition of JAK-STAT signaling promotes hair growth. Sci Adv 1(9):e1500973CrossRefGoogle Scholar
  7. 7.
    Kennedy Crispin M, Ko JM, Craiglow BG, Li S, Shankar G, Urban JR, Chen JC, Cerise JE, Jabbari A, Winge MCG, Marinkovich MP, Christiano AM, Oro AE, King BA safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight 1(15):e89776Google Scholar
  8. 8.
    Meephansan J, Thummakriengkrai J, Ponnikorn S, Yingmema W, Deenonpoe R, Suchonwanit P (2017) Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction. Arch Dermatol Res 309(9):729–738CrossRefGoogle Scholar
  9. 9.
    Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA, Stenn KS, Paus R (2001) A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 117:3–15CrossRefGoogle Scholar
  10. 10.
    Shin JA, Lim SM, Jeong SI, Kang JL, Park EM (2014) Noggin improves ischemic brain tissue repair and promotes alternative activation of microglia in mice. Brain Behav Immun 40:143–154CrossRefGoogle Scholar
  11. 11.
    Woo WM, Zhen HH, Oro AE (2012) Shh maintains dermal papilla identity and hair morphogenesis via a Noggin-Shh regulatory loop. Genes Dev 26:1235–1246CrossRefGoogle Scholar
  12. 12.
    Wright ET, Winer LH (1966) Topical application of dimethyl sulfoxide (DMSO) to skin of guinea pigs. A histopathological study. J Invest Dermatol 46(4):409–414CrossRefGoogle Scholar
  13. 13.
    Zimmerman LB, De Jesus-Escobar JM, Harland RM (1996) The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86(4):599–606CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Dermatology, Chulabhorn International College of MedicineThammasat University, Rangsit CampusKlong LuangThailand
  2. 2.Chulabhorn International College of MedicineThammasat University, Rangsit CampusKlong LuangThailand
  3. 3.Laboratory Animal CentersThammasat UniversityKlong LuangThailand

Personalised recommendations